Patient Engagement in Preclinical Research

Thank you

This live web event has ended. Thank you for attending.

Description

The IASP 2022 World Congress on Pain took place from 19-23 September 2022, in Toronto, Canada. As a part of the World Congress Virtual Program, IASP will host eleven Post-Congress webinars. These webinars will provide registrants with practical reviews of current research and therapies surrounding pain and will feature live Q&A sessions with international experts in pain management and pain research. The Virtual Program is available to all IASP 2022 World Congress on Pain registered attendees (i.e., both in-person and virtual registrants).

There are three pricing tiers for this Post-Congress webinar:
1) FREE to all IASP 2022 World Congress on Pain registered attendees (registrants must enter the promo code provided via email during checkout).
2) $5.00 USD for all IASP members that did not register to attend the IASP 2022 World Congress on Pain.
3) $25.00 USD for all IASP non-members that did not register to attend the IASP 2022 World Congress on Pain.

Patient Engagement in Preclinical Research

Through interview and discussion, this second Post-Congress webinar will bring to life what lived experience of pain means (how people's lives are affected by their pain and the choices that they make as a result) and why it is important that lived experience is integrated into pain research, education, knowledge dissemination, and treatment.

Patient engagement involves meaningful collaboration between researchers and Patient Partners to co-create research. We will draw upon examples from our experiences of how to set priorities, roles, and responsibilities for successful collaboration and discuss how to overcome barriers to patient engagement.

After an initial introduction, we aim to provide the audience the opportunity to drive the conversation, allowing them to raise their thoughts, concerns, and ideas about how researchers and patients can work more closely together.

Participants:
-- Joletta Belton, MSc, Global Alliance of Partners for Pain Advocacy
-- Manoj Lalu, MD, PhD, FRCPC, University of Ottawa, Canada
-- Nadia Soliman, PhD, Imperial College London, UK (moderator)

Learning Objectives (Upon Completion):

Recognize the importance of patient engagement to inform preclinical research.
Illustrate how people with lived experience can support identification of research priorities, design, and conduct of research.
Identify barriers for effective preclinical researcher/Patient Partner collaboration.

Contributors

Joletta Belton, MSc

Joletta Belton, MSc, is a medically retired firefighter/paramedic who has lived with pain since January 2010. She is co-chair of IASP’s Global Alliance of Partners for Pain Advocacy and is the first Patient and Public Partnerships Editor at the Journal of Orthopaedic and Sports Physical Therapy. Her advocacy work centers on equitably integrating lived experience into the study, research, and treatment of pain. She has presented on this topic at pain conferences and in classrooms around the world and has authored and co-authored peer-reviewed journal articles and textbook chapters. She has also been a Patient Partner on research projects in Canada, Australia, and the UK.
Manoj Lalu, MD, PhD, FRCPC

Manoj Lalu, MD, PhD, FRCPC, is an anesthesiologist and researcher focused on moving basic science discoveries to early phase clinical trials. He co-leads the Blueprint Translational Research Group in the Ottawa Hospital Research Institute at the University of Ottawa, Canada. The group adopts a variety of approaches to better understand and improve the "translational" process by optimizing preclinical to clinical translation (i.e., "bench-to-bedside"). At the bench, he believes this can be accomplished by improving methodological rigor and promoting transparent reporting. His research group is using knowledge synthesis methods (e.g., systematic reviews, systematic reviews/meta-research, qualitative interview studies, early economic analyses, preclinical lab studies, etc.) in order to improve translation of bench discoveries to first-in-human and early clinical trials. Moving to the bedside, he believes that interdisciplinary teams, including patients and other stakeholders, will help prevent failures and improve the efficiency of translation. His current research is largely preclinical and translational, focusing on cell therapies (e.g., mesenchymal stem cells, chimeric antigen receptor T-cells) for systemic inflammation that may be useful for cancer and cardiovascular disease.
Nadia Soliman, PhD

Nadia Soliman, PhD, is a postdoctoral researcher in Andrew Rice’s Pain Group at Imperial College London, UK. She focuses on developing methods to improve the feasibility, efficiency, and accuracy of preclinical systematic reviews while addressing neurobiological questions of interest to improve the predictive validity of animal research, the use of machine technologies, and the employment of crowd science to ensure that research conduct is rigorous, open, and transparent. She is the UK Reproducibility Network’s Local Network Lead and Badges and Preprint Editor at BMJ Open Science. She also has an interest in sharing her military experiences and knowledge of leadership development to engender a more positive research culture.